4//SEC Filing
Hindman Andrew A. 4
Accession 0001179110-21-005842
CIK 0001583107other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 6:10 PM ET
Size
4.7 KB
Accession
0001179110-21-005842
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2021-05-20$17.80/sh−942$16,768→ 184,844 total
Footnotes (1)
- [F1]Includes 1,082 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 6:10 PM ET
- Size
- 4.7 KB